Navigation Links
UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key
Date:10/10/2007

SEATTLE, Oct. 9 /PRNewswire/ -- Emergency departments (ED) hold a critical key in improving acute coronary syndromes (ACS) outcomes. Does your community- based ED have all the tools that you need to improve ACS care? This CME- certified symposium, "Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key," will be led by top ED - cardiology experts, Deborah Diercks, MD; James Hoekstra, MD; and Charles Pollack, Jr., MD. They will describe ways in which community-based EDs can apply new treatment guidelines and clinical trial evidence to their chest pain patients treated for ACS. As chest pain represents the second-largest patient population that EDs treat, this interactive, case-based session will provide a lively description of how ED health care providers can continue to advance treatment and outcomes for this prevalent population, through improved triage and diagnosis, shortened door to balloon/needle times, and optimal upstream adjuvant therapy.

The free CME-certified Webcast will be presented on October 10, from 5:30 AM to 8:00 AM. Broadcast live during the American College of Emergency Physicians Scientific Assembly, this innovative, case-based symposium will provide emergency physicians and other clinicians with detailed information on treating patients with acute myocardial infarction. This activity is sponsored by INNOVIA Education Institute and supported by and educational grant from sanofi-aventis, U.S.

TITLE: Opening the Door to Better Myocardial Infarction Outcomes:

Emergency Departments Hold the Key

FACULTY: Deborah B. Diercks, MD, University of California, Davis;

James W. Hoekstra, MD, Wake Forest University Baptist

Medical Center; Charles V. Pollack, Jr., MD, Pennsylvania

Hospital

WHEN: Wednesday, October 10, 2007; 6:00 AM-8:00 AM PST

WHERE: http://www.iian.ibeam.com/events/mult001/23889/

HOW: Live over the Internet-simply log on to the above web site.

The CME-certified Webcast will be archived shortly after the

live presentation and made available for download for 1

year.

CREDIT HOURS: INNOVIA Education Institute designates this educational

activity for a maximum of 2 AMA PRA Category 1 Credit(s)TM.

Physicians should only claim credit commensurate with the

extent of their participation in the activity.

LEARNING OBJECTIVES As a result of participating in this symposium, learners will be able to:

-- Apply new clinical trial data and treatment guidelines to acute ACS

management in the community-based ED

-- Adapt evidence-based approaches to acute ACS care to diverse patient

populations, including older individuals as well as patients with

renal dysfunction and other co-morbid conditions

-- Employ systematic approaches EDs can take to improve ACS outcomes

-- Integrate ACS treatment data into algorithms for hospital EDs with

various PCI capabilities and transfer policies

PROGRAM OVERVIEW

This symposium will provide an opportunity to review recent developments in the treatment of ACS in the ED setting through the lens of patient cases that the participants submit. Through a highly-interactive format, participants will work to apply new treatment guidelines and research evidence to diverse ACS patient populations and ED-practice settings.

ABOUT INNOVIA EDUCATION INSTITUTE

INNOVIA Education Institute, LLC, the coordinator of this educational activity, has been an accredited provider of continuing medical education (CME) for physicians since 1988. Headquartered in Columbia, MD, INNOVIA Education Institute is dedicated to independent, science-based communications for health care product manufacturers and quality professional education with the goal of providing information to health care providers that ultimately improves patient care. Find out more information about INNOVIA at http://innoviaeducation.com .

CONTACT INFORMATION

For more information about the program, please contact Karen Gatzke at (410) 312-3548 or kgatzke@innoviaeducation.com .


'/>"/>
SOURCE INNOVIA Education Institute, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Merge files financial reports by market opening
2. HotMasterAn innovative Hot Start/Cold Stop technology for better PCR* results
3. A Better Way to Isolate RNA AND Protein From the Same Sample
4. Better RNA Amplification
5. Designing a Better siRNA
6. IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER!
7. RNA Amplification Just Got Better: MessageAmp II
8. Wisconsin fares slightly better in venture capital chase
9. Economic survey reveals better 2006 results
10. Technology changing for better, Coburn says
11. Internet Scout Project develops better tools for online research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Pa. , Feb. 16, 2017  Windtree ... biotechnology company focusing on developing aerosolized KL4 surfactant ... from a preclinical influenza study showed that aerosolized ... survival in a well-established preclinical animal model. The ... a growing body of evidence that supports the ...
(Date:2/15/2017)... (PRWEB) , ... February 15, 2017 , ... ... Posard, as President and Chief Commercial Officer with GenePeeks. Matt is a ... , GenePeeks is a computational genomics company focused on identifying inherited disease risk ...
(Date:2/15/2017)... WASHINGTON, Feb. 15, 2017  Vanda Pharmaceuticals Inc. ... results for the fourth quarter and full year ... an exceptional year for Vanda as we continued ... and secured long-term exclusivity for Fanapt," said Mihael ... addition, our emerging pipeline with important 2017 milestones ...
(Date:2/15/2017)... ... February 15, 2017 , ... Diameter Health (Diameter) ... Health technology in the hands of Lantana analysts. The high-performance platform of Diameter ... public health entities – all those mining value from clinical data – to ...
Breaking Biology Technology:
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, Inc. ... immuno-oncology company specializing in the development of innovative ... treatment of cancer and metastatic disease, announced today ... GMP manufacturing of a second clinical lot of ... folate receptor alpha. The manufactured vaccine product will ...
(Date:1/31/2017)... Mass. , Jan. 31, 2017  Spero ... novel therapies for the treatment of bacterial infections, ... set of antibacterial candidates from Pro Bono Bio ... increased prevalence of multi-drug resistant forms of Gram-negative ... Cantab Anti Infectives Ltd, a PBB group company. ...
(Date:1/25/2017)... , Jan. 25, 2017 The Elements ... Management (IAM) lifecycle is comprised of a comprehensive ... the purpose of maintaining digital identities and providing ... and applications. There are significant number of programs ... time to time by optimizing processes and changing ...
Breaking Biology News(10 mins):